Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 563403, 13 pages
http://dx.doi.org/10.1155/2015/563403
Review Article

Role of Vitamin D Deficiency in Extraskeletal Complications: Predictor of Health Outcome or Marker of Health Status?

1Unit of Population Epidemiology, Department of Community Medicine and Primary Care and Emergency Medicine, Geneva University Hospitals, 1214 Geneva, Switzerland
2Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, 1010 Lausanne, Switzerland
3Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 1518, USA

Received 30 October 2014; Accepted 9 January 2015

Academic Editor: Domenico Santoro

Copyright © 2015 Idris Guessous. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Holick, “Evolution, biologic functions, and recommended dietary allowances for vitamin D,” in Vitamin D: Molecular Biology, Physiology, and Clinical Applications: Nutrition and Health, Nutrition and Health, pp. 1–16, Humana Press, 1999. View at Google Scholar
  2. M. F. Holick, “McCollum Award Lecture, 1994: vitamin D—new horizons for the 21st century,” The American Journal of Clinical Nutrition, vol. 60, no. 4, pp. 619–630, 1994. View at Google Scholar
  3. M. Wacker and M. F. Holick, “Sunlight and Vitamin D: a global perspective for health,” Dermato-Endocrinology, vol. 5, no. 1, pp. 51–108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. B. A. Gilchrest, “Sun exposure and vitamin D sufficiency,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 570S–577S, 2008. View at Google Scholar · View at Scopus
  5. A. G. Uitterlinden, Y. Fang, J. B. J. van Meurs, H. A. P. Pols, and J. P. T. M. van Leeuwen, “Genetics and biology of vitamin D receptor polymorphisms,” Gene, vol. 338, no. 2, pp. 143–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Feldman, J. W. Pike, and J. S. Adams, Vitamin D, Academic Press, 2011.
  7. T.-T. Wang, L. E. Tavera-Mendoza, D. Laperriere et al., “Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes,” Molecular Endocrinology, vol. 19, no. 11, pp. 2685–2695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Schuster, “Cytochromes P450 are essential players in the vitamin D signaling system,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1814, no. 1, pp. 186–199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. N. M. van Schoor and P. Lips, “Worldwide vitamin D status,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 25, no. 4, pp. 671–680, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Pludowski, W. B. Grant, H. P. Bhattoa et al., “Vitamin D status in central Europe,” International Journal of Endocrinology, vol. 2014, Article ID 589587, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. F. Holick and T. C. Chen, “Vitamin D deficiency: a worldwide problem with health consequences,” The American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 1080S–1086S, 2008. View at Google Scholar · View at Scopus
  12. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Guessous, V. Dudler, N. Glatz et al., “Vitamin D levels and associated factors: a population-based study in Switzerland,” Swiss Medical Weekly, vol. 142, Article ID w13719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Pilz, A. Tomaschitz, W. März et al., “Vitamin D, cardiovascular disease and mortality,” Clinical Endocrinology, vol. 75, no. 5, pp. 575–584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Durup, H. L. Jørgensen, J. Christensen, P. Schwarz, A. M. Heegaard, and B. Lind, “A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 8, pp. 2644–2652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. C. Ross, J. E. Manson, S. A. Abrams et al., “The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 53–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. “KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD),” Kidney International Supplements, no. 113, pp. S1–S130, 2009.
  18. B. Troesch, B. Hoeft, M. McBurney, M. Eggersdorfer, and P. Weber, “Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries,” British Journal of Nutrition, vol. 108, no. 4, pp. 692–698, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. D. de Abreu, I. Guessous, J.-M. Gaspoz, and P. Marques-Vidal, “Compliance with the Swiss society for nutrition's dietary recommendations in the population of Geneva, Switzerland: a 10-year trend study (1999–2009),” Journal of the Academy of Nutrition and Dietetics, vol. 114, no. 5, pp. 774–780, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Bendik, A. Friedel, F. F. Roos, P. Weber, and M. Eggersdorfer, “Vitamin D: a critical and essential micronutrient for human health,” Frontiers in Physiology, vol. 5, article 248, 2014. View at Publisher · View at Google Scholar
  21. H. K. Biesalski, “International congress ‘hidden hunger’, March 5–9, 2013, Stuttgart-Hohenheim, Germany,” Annals of Nutrition and Metabolism, vol. 62, no. 4, pp. 298–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. F. Holick, “Vitamin D: a millenium perspective,” Journal of Cellular Biochemistry, vol. 88, no. 2, pp. 296–307, 2003. View at Google Scholar
  23. M. G. Kimlin, “Geographic location and vitamin D synthesis,” Molecular Aspects of Medicine, vol. 29, no. 6, pp. 453–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. J. Wang, M. J. Pencina, S. L. Booth et al., “Vitamin D deficiency and risk of cardiovascular disease,” Circulation, vol. 117, no. 4, pp. 503–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Marti-Soler, C. Gubelmann, S. Aeschbacher et al., “Seasonality of cardiovascular risk factors: an analysis including over 230, 000 participants in 15 countries,” Heart, vol. 100, no. 9, pp. 1517–1523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Davis, “Vitamin D and cancer: current dilemmas and future research needs,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 565S–569S, 2008. View at Google Scholar
  27. C. L. Hanchette and G. G. Schwartz, “Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation,” Cancer, vol. 70, no. 12, pp. 2861–2869, 1992. View at Publisher · View at Google Scholar
  28. M. R. Haussler, “Vitamin D receptors: nature and function,” Annual Review of Nutrition, vol. 6, pp. 527–562, 1986. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Carlberg, “Genome-wide (over)view on the actions of vitamin D,” Frontiers in Physiology, vol. 5, article 167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Wang, J. Zhu, and H. F. DeLuca, “Where is the vitamin D receptor?” Archives of Biochemistry and Biophysics, vol. 523, no. 1, pp. 123–133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Guessous and M. Bochud, “Opposite impacts of dietary versus supplemental calcium on cardiovascular health,” Evidence-Based Medicine, vol. 18, no. 3, pp. 113–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Guessous and M. Bochud, “Effects of calcium and vitamin D supplementations on cardiovascular disease: review article,” Revue Médicale Suisse, vol. 8, no. 348, pp. 1458–1463, 2012. View at Google Scholar · View at Scopus
  33. H. Wasse, F. Cardarelli, C. de Staercke, C. Hooper, E. Veledar, and I. Guessous, “25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients,” BMC Nephrology, vol. 12, no. 1, article 24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Guessous, M. Bochud, O. Bonny, and M. Burnier, “Calcium, vitamin D and cardiovascular disease,” Kidney and Blood Pressure Research, vol. 34, no. 6, pp. 404–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. T. A. Pearson and T. A. Manolio, “How to interpret a genome-wide association study,” The Journal of the American Medical Association, vol. 299, no. 11, pp. 1335–1344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. D. P. McDonnell, D. J. Mangelsdorf, J. W. Pike, M. R. Haussler, and B. W. O'Malley, “Molecular cloning of complementary DNA encoding the avian receptor for vitamin D,” Science, vol. 235, no. 4793, pp. 1214–1217, 1987. View at Publisher · View at Google Scholar · View at Scopus
  37. A. G. Uitterlinden, Y. Fang, J. B. J. van Meurs, H. van Leeuwen, and H. A. P. Pols, “Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states,” Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, no. 1–5, pp. 187–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Arai, K.-I. Miyamoto, M. Yoshida et al., “The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene,” Journal of Bone and Mineral Research, vol. 16, no. 7, pp. 1256–1264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. H. A. Morris and P. H. Anderson, “Autocrine and paracrine actions of vitamin D,” The Clinical Biochemist Reviews, vol. 31, no. 4, pp. 129–138, 2010. View at Google Scholar
  40. W. Xiang, J. Kong, S. Chen et al., “Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 288, no. 1, pp. E125–E132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Kong, G. Qiao, Z. Zhang, S. Q. Liu, and Y. C. Li, “Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium,” Kidney International, vol. 74, no. 12, pp. 1577–1581, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Pilz, A. Tomaschitz, E. Ritz, and T. R. Pieber, “Vitamin D status and arterial hypertension: a systematic review,” Nature Reviews Cardiology, vol. 6, no. 10, pp. 621–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. S. K. Wong, R. Delansorne, R. Y. K. Man, and P. M. Vanhoutte, “Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 295, no. 1, pp. H289–H296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Zittermann, S. S. Schleithoff, and R. Koerfer, “Putting cardiovascular disease and vitamin D insufficiency into perspective,” British Journal of Nutrition, vol. 94, no. 4, pp. 483–492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. T. D. O'Connell, J. E. Berry, A. K. Jarvis, M. J. Somerman, and R. U. Simpson, “1,25-dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 272, no. 4, part 2, pp. H1751–H1758, 1997. View at Google Scholar · View at Scopus
  46. K. E. Watson, M. L. Abrolat, L. L. Malone et al., “Active serum vitamin D levels are inversely correlated with coronary calcification,” Circulation, vol. 96, no. 6, pp. 1755–1760, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Penckofer, J. Kouba, D. E. Wallis, and M. A. Emanuele, “Vitamin D and diabetes: let the sunshine in,” Diabetes Educator, vol. 34, no. 6, pp. 939–954, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes, “The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2017–2029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Yin and D. K. Agrawal, “Vitamin D and inflammatory diseases,” Journal of Inflammation Research, vol. 7, no. 1, pp. 69–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. T. K. Wobke, B. L. Sorg, and D. Steinhilber, “Vitamin D in inflammatory diseases,” Frontiers in Physiology, vol. 5, article 244, 2014. View at Publisher · View at Google Scholar
  51. S. Mordan-Mccombs, M. Valrance, G. Zinser, M. Tenniswood, and J. Welsh, “Calcium, vitamin D and the vitamin D receptor: impact on prostate and breast cancer in preclinical models,” Nutrition Reviews, vol. 65, no. 8, part 2, pp. S131–S133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Ahmad, T. A. Chowdhury, and B. J. Boucher, “Diabetes and cancer: could vitamin D provide the link?” Journal of Diabetes and Its Complications, vol. 27, no. 2, pp. 184–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” The American Journal of Kidney Diseases, vol. 39, no. 2, supplement 1, pp. S1–S266, 2002. View at Google Scholar
  54. F. Duranton, M. E. Rodriguez-Ortiz, Y. Duny, M. Rodriguez, J. P. Daurès, and A. Argilés, “Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis,” The American Journal of Nephrology, vol. 37, no. 3, pp. 239–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Zheng, H. Shi, J. Jia, D. Li, and S. Lin, “Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies,” BMC Nephrology, vol. 14, article 199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. G. Bonizzi and M. Karin, “The two NF-kappaB activation pathways and their role in innate and adaptive immunity,” Trends in Immunology, vol. 25, no. 6, pp. 280–288, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Guijarro and J. Egido, “Transcription factor-κB (NF-κB) and renal disease,” Kidney International, vol. 59, no. 2, pp. 415–424, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Giovannucci, Y. Liu, B. W. Hollis, and E. B. Rimm, “25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study,” Archives of Internal Medicine, vol. 168, no. 11, pp. 1174–1180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Marniemi, E. Alanen, O. Impivaara et al., “Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 3, pp. 188–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. W. B. Grant, H. S. Cross, C. F. Garland et al., “Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe,” Progress in Biophysics and Molecular Biology, vol. 99, no. 2-3, pp. 104–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Pfeifer, B. Begerow, H. W. Minne, D. Nachtigall, and C. Hansen, “Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1633–1637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. D. P. Trivedi, R. Doll, and K. T. Khaw, “Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial,” The British Medical Journal, vol. 326, no. 7387, pp. 469–472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Z. LaCroix, J. Kotchen, G. Anderson et al., “Calcium plus vitamin D supplementation and mortality in postmenopausal women: the women's health initiative calcium-vitamin D randomized controlled trial,” Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 64, no. 5, pp. 559–567, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. E. Theodoratou, I. Tzoulaki, L. Zgaga, and J. P. A. Ioannidis, “Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials,” The British Medical Journal, vol. 348, Article ID g2035, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. M. J. Bolland, A. Grey, G. D. Gamble, and I. R. Reid, “The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis,” The Lancet Diabetes & Endocrinology, vol. 2, no. 4, pp. 307–320, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. M. J. Bolland, A. Grey, G. D. Gamble, and I. R. Reid, “Vitamin D supplementation and falls: a trial sequential meta-analysis,” The Lancet Diabetes & Endocrinology, vol. 2, no. 7, pp. 573–580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. C. F. Garland, E. D. Gorham, S. B. Mohr, and F. C. Garland, “Vitamin D for cancer prevention: global perspective,” Annals of Epidemiology, vol. 19, no. 7, pp. 468–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Chung, J. Lee, T. Terasawa, J. Lau, and T. A. Trikalinos, “Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force,” Annals of Internal Medicine, vol. 155, no. 12, pp. 827–838, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. K. D. Cashman, “A review of vitamin D status and CVD,” Proceedings of the Nutrition Society, vol. 73, no. 1, pp. 65–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  70. M. B. Elamin, N. O. Abu Elnour, K. B. Elamin et al., “Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1931–1942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Muldowney and M. Kiely, “Vitamin D and cardiometabolic health: a review of the evidence,” Nutrition Research Reviews, vol. 24, no. 1, pp. 1–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. J. A. Ford, G. S. MacLennan, A. Avenell, M. Bolland, A. Grey, and M. Witham, “Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis,” The American Journal of Clinical Nutrition, vol. 100, no. 3, pp. 746–755, 2014. View at Publisher · View at Google Scholar
  73. V. Kunadian, G. A. Ford, B. Bawamia, W. Qiu, and J. E. Manson, “Vitamin D deficiency and coronary artery disease: a review of the evidence,” The American Heart Journal, vol. 167, no. 3, pp. 283–291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. P. Messa, M. Curreri, A. Regalia, and C. M. Alfieri, “Vitamin D and the cardiovascular system: an overview of the recent literature,” The American Journal of Cardiovascular Drugs, vol. 14, no. 1, pp. 1–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Muscogiuri, J. Mitri, C. Mathieu et al., “Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease,” European Journal of Endocrinology, vol. 171, no. 3, pp. R101–R110, 2014. View at Publisher · View at Google Scholar
  76. R. Chowdhury, S. Kunutsor, A. Vitezova et al., “Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies,” The British Medical Journal, vol. 348, Article ID g1903, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. P. Pludowski, M. F. Holick, S. Pilz et al., “Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence,” Autoimmunity Reviews, vol. 12, no. 10, pp. 976–989, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. N. C. Harvey and C. Cooper, “Vitamin D: some perspective please,” The British Medical Journal, vol. 345, no. 7869, Article ID e4695, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Richart, Y. Li, and J. A. Staessen, “Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension,” The American Journal of Hypertension, vol. 20, no. 9, pp. 1007–1015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. K. P. Schlingmann, M. Kaufmann, S. Weber et al., “Mutations in CYP24A1 and idiopathic infantile hypercalcemia,” The New England Journal of Medicine, vol. 365, no. 5, pp. 410–421, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. K. M. Sanders, A. L. Stuart, E. J. Williamson et al., “Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial,” The Journal of the American Medical Association, vol. 303, no. 18, pp. 1815–1822, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. K. M. Sanders, G. C. Nicholson, and P. R. Ebeling, “Is high dose vitamin D harmful?” Calcified Tissue International, vol. 92, no. 2, pp. 191–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Welsh and N. Sattar, “Vitamin D and chronic disease prevention,” The British Medical Journal, vol. 348, Article ID g2280, 2014. View at Google Scholar
  84. S. Yusuf, G. Dagenais, J. Pogue, J. Bosch, and P. Sleight, “Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators,” The New England Journal of Medicine, vol. 342, no. 3, pp. 154–160, 2000. View at Publisher · View at Google Scholar
  85. B. K. Dunn, E. S. Richmond, L. M. Minasian, A. M. Ryan, and L. G. Ford, “A nutrient approach to prostate cancer prevention: the selenium and vitamin E cancer prevention trial (SELECT),” Nutrition and Cancer, vol. 62, no. 7, pp. 896–918, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al., “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial,” The Journal of the American Medical Association, vol. 288, no. 3, pp. 321–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. K. Muse, “After the Women's Health initiative-what to tell our patients,” Southern Medical Journal, vol. 95, no. 9, pp. 957–959, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. O. S. Miettinen, “The clinical trial as a paradigm for epidemiologic research,” Journal of Clinical Epidemiology, vol. 42, no. 6, pp. 491–498, 1989. View at Publisher · View at Google Scholar · View at Scopus
  89. K. J. Rothman, S. Greenland, and T. L. Lash, Modern Epidemiology, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2008.
  90. P. Lips, T. Duong, A. Oleksik et al., “A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 3, pp. 1212–1221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Hyppönen and C. Power, “Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors,” The American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 860–868, 2007. View at Google Scholar · View at Scopus
  92. T. Hagenau, R. Vest, T. N. Gissel et al., “Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis,” Osteoporosis International, vol. 20, no. 1, pp. 133–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Lips, “Vitamin D status and nutrition in Europe and Asia,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3–5, pp. 620–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. I. S. Fetahu, J. Hobaus, and E. Kallay, “Vitamin D and the epigenome,” Frontiers in Physiology, vol. 5, article 164, 2014. View at Google Scholar
  95. K. M. Flegal, B. I. Graubard, D. F. Williamson, and R. S. Cooper, “Reverse causation and illness-related weight loss in observational studies of body weight and mortality,” The American Journal of Epidemiology, vol. 173, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. P. Autier, M. Boniol, C. Pizot, and P. Mullie, “Vitamin D status and ill health: a systematic review,” The Lancet Diabetes & Endocrinology, vol. 2, no. 1, pp. 76–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. R. Gama, J. L. Waldron, H. L. Ashby et al., “Hypovitaminosis D and disease: consequence rather than cause?” The British Medical Journal, vol. 345, no. 7872, Article ID e5706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Bochud, “On the use of Mendelian randomization to infer causality in observational epidemiology,” European Heart Journal, vol. 29, no. 20, pp. 2456–2457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Bochud and V. Rousson, “Usefulness of Mendelian randomization in observational epidemiology,” International Journal of Environmental Research and Public Health, vol. 7, no. 3, pp. 711–728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. S. K. Kunutsor, S. Burgess, P. B. Munroe, and H. Khan, “Vitamin D and high blood pressure: causal association or epiphenomenon?” European Journal of Epidemiology, vol. 29, no. 1, pp. 1–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. K. S. Vimaleswaran, A. Cavadino, D. J. Berry et al., “Association of vitamin D status with arterial blood pressure and hypertension risk: a Mendelian randomisation study,” The Lancet Diabetes & Endocrinology, vol. 2, no. 9, pp. 719–729, 2014. View at Publisher · View at Google Scholar
  102. Z. Ye, S. J. Sharp, S. Burgess et al., “Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study,” The Lancet Diabetes & Endocrinology, vol. 3, no. 1, pp. 35–42, 2015. View at Publisher · View at Google Scholar
  103. A. M. Rose, “Vitamin D testing: clinical and laboratory considerations,” Medical Laboratory Observer, vol. 45, no. 5, pp. 8–14, 2013. View at Google Scholar
  104. A. Prentice, G. R. Goldberg, and I. Schoenmakers, “Vitamin D across the lifecycle: physiology and biomarkers,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 500S–506S, 2008. View at Google Scholar · View at Scopus
  105. I. Tzoulaki, K. C. Siontis, E. Evangelou, and J. P. A. Ioannidis, “Bias in associations of emerging biomarkers with cardiovascular disease,” JAMA Internal Medicine, vol. 173, no. 8, pp. 664–671, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. C. J. L. Farrell, S. Martin, B. McWhinney, I. Straub, P. Williams, and M. Herrmann, “State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods,” Clinical Chemistry, vol. 58, no. 3, pp. 531–542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. B. W. Hollis, “Assessment of circulating 25(OH)D and 1,25(OH)2D: emergence as clinically important diagnostic tools,” Nutrition Reviews, vol. 65, no. 8, part 2, pp. S87–S90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. S. J. Bruce, B. Rochat, A. Béguin et al., “Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry—a method comparison and validation,” Rapid Communications in Mass Spectrometry, vol. 27, no. 1, pp. 200–206, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Giovannucci, “Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk,” Nutrition Reviews, vol. 65, no. 8, part 2, pp. S77–S79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. F. R. Greer, “25-Hydroxyvitamin D: functional outcomes in infants and young children,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 529S–533S, 2008. View at Google Scholar · View at Scopus
  111. C. J. E. Lamberg-Allardt and H. T. Viljakainen, “25-Hydroxyvitamin D and functional outcomes in adolescents,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 534S–536S, 2008. View at Google Scholar · View at Scopus
  112. B. Dawson-Hughes, “Serum 25-hydroxyvitamin D and functional outcomes in the elderly,” The American Journal of Clinical Nutrition, vol. 88, no. 2, pp. 537S–540S, 2008. View at Google Scholar · View at Scopus
  113. J. E. Manson, S. S. Bassuk, I.-M. Lee et al., “The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease,” Contemporary Clinical Trials, vol. 33, no. 1, pp. 159–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  114. S. Pilz, K. Kienreich, A. Tomaschitz et al., “Vitamin D and cardiovascular disease: update and outlook,” Scandinavian Journal of Clinical and Laboratory Investigation Supplements, vol. 243, pp. 83–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. S. Pilz, F. Rutters, and J. M. Dekker, “Disease prevention: vitamin D trials,” Science, vol. 338, no. 6109, p. 883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Michaëlsson, “The puzzling world of vitamin D insufficiency,” The Lancet Diabetes & Endocrinology, vol. 2, no. 4, pp. 269–270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. “Vitamin D: chasing a myth?” The Lancet Diabetes & Endocrinology, vol. 2, no. 1, p. 1, 2014. View at Publisher · View at Google Scholar
  118. V. Prasad, A. Cifu, and J. P. A. Ioannidis, “Reversals of established medical practices: evidence to abandon ship,” The Journal of the American Medical Association, vol. 307, no. 1, pp. 37–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. I. Guessous and M. Bochud, “Reply to the letter to the editor ‘Vitamin D deficiency and cardiovascular disease’ by Ahmed et al,” Swiss Medical Weekly, vol. 143, Article ID w13822, 2013. View at Publisher · View at Google Scholar
  120. J. P. A. Ioannidis, “Biomarker failures,” Clinical Chemistry, vol. 59, no. 1, pp. 202–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. K. Kupferschmidt, “Uncertain verdict as vitamin D goes on trial,” Science, vol. 337, no. 6101, pp. 1476–1478, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. N. Sattar, P. Welsh, M. Panarelli, and N. G. Forouhi, “Increasing requests for vitamin D measurement: costly, confusing, and without credibility,” The Lancet, vol. 379, no. 9811, pp. 95–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. R. H. Fletcher, “Review: vitamin D3 supplementation may reduce mortality in adults; vitamin D2 does not,” Annals of Internal Medicine, vol. 161, no. 2, article JC5, 2014. View at Publisher · View at Google Scholar
  124. I. R. Reid, M. J. Bolland, and A. Grey, “Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis,” The Lancet, vol. 383, no. 9912, pp. 146–155, 2014. View at Publisher · View at Google Scholar · View at Scopus